SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001661539-22-000005
Filing Date
2022-02-03
Accepted
2022-02-03 17:36:41
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164392778280060.html 4  
1 FORM 4 wf-form4_164392778280060.xml 4 6289
  Complete submission text file 0001661539-22-000005.txt   7670
Mailing Address C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139
Business Address
Trevejo Jose M. (Reporting) CIK: 0001661539 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 22589898

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)